期刊文献+

甲状腺激素对大鼠解偶联蛋白-2基因表达的影响 被引量:1

Effect of thyroid hormone on uncoupling protein-2 gene expression in rats
在线阅读 下载PDF
导出
摘要 目的:探讨甲状腺激素对大鼠骨骼肌组织(SM)、肝组织(LV)和白色脂肪组织(WAT)中解偶联蛋白-2(UCP2)基因表达的影响。方法:正常雄性Wistar大鼠30只,随机分为对照组、甲状腺功能亢进(甲亢)组和甲状腺功能低下(甲低)组,应用左旋甲状腺素钠和甲巯咪唑造成大鼠甲亢和甲低状态;用放免法检测血清总T3、T4的浓度;用半定量逆转录聚合酶链反应(RT-PCR)检测SM、LV和WAT中UCP2mRNA的表达水平。结果:与对照组相比,甲亢组大鼠SM、LV和WAT中UCP2mRNA的水平分别增加了65%、50%和40%,甲低组大鼠SM、LV和WAT中UCP2mRNA的水平分别降低了9%、24%和20%,差异均具有统计学意义,P<0.05。结论:过量甲状腺激素对SM、LV和WAT中UCP2基因的表达具有上调作用,甲状腺激素水平过低则下调SM、LV和WAT中UCP2基因的表达。 Objective: To investigate the effect of thyroid hormone on uncoupling protein-2 (UCP2) gene expression in skeleton muscle (SM), liver (LV) and white adipose tissue (WAT) in rats. Methods: Thirty normal male Wistar rats were averaged into three groups at random: control, hyperthyroid and hypothyroid. The hyperthyroid or hypothyroid status was made by administration of L-Thyroxine or methimazol. The serum total T3 and T4 concentrations were measured by radioimmunoassay (RIA). The RNA levels of UCP2 in SM, LV and WAT were detected by semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Results: Compared with the normal control, UCP2 mRNA in SM, LV and WAT increased by 65%, 50%, 40% and decreased by 9%, 24%, 20% in hyperthyroid and hypothyroid groups. The differences had statistical significance (P〈0.05). Conclusion: Gene expression of UCP2 in SM, LV and WAT in rats is up-regulated by excessive thyroid hormone, and is down-regulated by low level of thyroid hormone.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第2期196-199,共4页 Journal of Shandong University:Health Sciences
关键词 甲状腺激素类 解偶联蛋白=2 基因表达 逆转录聚合酶链反应 Thyroid hormones Uncoupling protein-2 Gene expression Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献10

  • 1王健,裴维君,刘思敏.甲状腺功能异常大鼠血浆心纳素和肾素相关性的探讨[J].中国病理生理杂志,1993,9(6):712-714. 被引量:1
  • 2Shimabukuro M,Zhou YT,Lee Y,et al.Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats[J].Biochem Biophys Res Commun,1997,237(2):359-361.
  • 3Gimeno RE,Dembski M,Weng X,et al.Cloning and characterization of an uncoupling protein homolog:a potential molecular mediator of human thermogenesis[J].Diabetes,1997,46(5):900-906.
  • 4Hidaka S,Kakuma T,Yoshimatsu H,et al.Molecular cloning of rat uncoupling protein 2 cDNA and its expression in genetically obese Zucker fatty(fa/fa)rats[J].Biochim Biophys Acta,1998,1389(3):178-186.
  • 5Gomez-Ambrosi J,Fruhbeck G,Martinez JA,et al.Interactions between an alpha2-adrenergic antagonist and a beta3-adrenergic agonist on the expression of UCP2and UCP3 in rats[J].J Physiol Biochem,2002,58(1):17-23.
  • 6Rousset S,Alves-Guerra MC,Mozo J,et al.The biology of mitochondrial uncoupling proteins[J].Diabetes,2004,53 Suppl 1:130-135.
  • 7Hammarstedt A,Smith U.Thiazolidinediones(PPARgamma ligands)increase IRS-1,UCP-2 and C/EBPalpha expression,but not transdifferentiation,in L6 muscle cells[J].Diabetologia,2003,46(1):48-52.
  • 8Lopez SI,Marie V,Camirand A,et al.Regulation of uncoupling protein-2 mRNA in L6 myotubules:Ⅱ:Thyroid hormone amplifies stimulation of uncoupling protein-2 gene by thiazolidines and other peroxisome proliferatoractivated receptor ligands in L6 myotubules:evidence for a priming effect[J].Endocrine,2002,19(2):209-217.
  • 9Masaki T,Yoshimatsu H,Sakata T.Expression of rat uncoupling protein family mRNA levels by chronic treatment with thyroid hormone[J].Int J Obes Relat Metab Disord,2000,Suppl 2:162-164.
  • 10Lanni A,Moreno M,Lombardi A,et al.Thyroid hormone and uncoupling proteins[J].FEBS Lett,2003,543(1-3):5-10.

同被引文献10

  • 1Dietrich J W,Stachon A,Antic B,et al.The aqua-fontis study:Protocol of a multidisciplinary,cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome[J].BMC Endocr Disord,2008,8,13.
  • 2Adler S M,Wartofsky L.The nonthyroidal illness syndrome[J].Endocrinol Metab Clin North Am,2007,36(3):657.
  • 3Pisani M A.Considerations in caring for the critically ill older patient[J].J Intensive Care Med,2009,24(2):83.
  • 4Iglesias P,Munoz A,Prado F,et al.Alterations in thyroid function tests in aged hospitalized patients:Prevalence,aetiology and clinical outcome[J].Clin Endocrinol (Oxf),2009,70(6):961.
  • 5Warner M H,Beckett G J.Mechanisms behind the nonthyroidal illness syndrome:An update[J].J Endocrinol,2010,205(1):1.
  • 6Forestier E,Vinzio S,Sapin R,et al.Increased reversetriiodothyronine is associated with shorter survival in independently-living elderly:The alsanut study[J].Eur J Endocrinol,2009,160(2):207.
  • 7Tognini S,Marchini F,Dardano A,et al.Non-thyroidal illness syndrome and short-term survival in a hospitalised older population[J].Age Ageing,2010,39(1):46.
  • 8胡善友,刘跃.危重病患者非甲状腺疾病综合征的临床观察[J].中华老年多器官疾病杂志,2010,9(4):359-359. 被引量:5
  • 9罗洁,王德明.非甲状腺疾病综合征对危重症患者的影响[J].中国实用医药,2010,5(36):247-248. 被引量:13
  • 10刘星君.非甲状腺性病态患者手术后甲状腺激素的治疗:系统文献回顾和分析[J].中华内分泌代谢杂志,2011,27(4):339-341. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部